Physician
Healthtexas Provider Network
Healthtexas Provider Network was paid $3.72M by Medicaid between Jan 2018 and Dec 2024, across 131 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoHEALTHTEXAS PROVIDER NETWORK
DALLAS, TX 75246
DALLAS, TX 75246
33aNPI1760488936assigned 06/22/2005
33bProvider typeDermatology Physician
28Total paid$3.72M
24GClaims286,749
24DCodes billed131
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dermatology Physician providers in Texas
Rank by total paid#3 of 56
Median peer was paid$8K
This provider vs. median493×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,832 | $61K | |
| 2019 | 10,585 | $24K | |
| 2020 | 35,459 | $212K | |
| 2021 | 80,780 | $1.17M | |
| 2022 | 70,223 | $1.18M | |
| 2023 | 55,635 | $790K | |
| 2024incomplete | 28,235 | $277K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 18,366 | 16,322 | $779K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 22,520 | 19,481 | $706K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.8% | 3,580 | 3,269 | $291K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.7% | 3,866 | 3,560 | $287K |
| 87428 | 6.6% | 4,395 | 4,077 | $247K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.4% | 13,621 | 11,947 | $163K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.8% | 4,941 | 3,889 | $141K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 3.7% | 2,015 | 983 | $138K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.5% | 2,404 | 2,196 | $129K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.1% | 15,900 | 7,499 | $116K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.9% | 3,554 | 1,780 | $107K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.7% | 4,610 | 2,075 | $101K |
119 more codes
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.6% | 30,678 | $98K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 1,285 | $88K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 4,215 | $47K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 2,150 | $45K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.0% | 2,001 | $37K |
| 92551 | <1% | 5,067 | $33K | |
| 99223 | Prolong inpt eval add15 m | <1% | 194 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,290 | $11K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,619 | $11K |
| 90461 | <1% | 1,619 | $11K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 181 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 534 | $8K |
| 80050 | General health panel | <1% | 768 | $8K |
| 99349 | <1% | 408 | $7K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,103 | $6K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 87 | $6K |
| 99350 | Prolong home eval add 15m | <1% | 304 | $5K |
| 96127 | <1% | 1,727 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,790 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 551 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 534 | $4K |
| 80061 | Lipid panel | <1% | 11,825 | $3K |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 189 | $3K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 68 | $3K |
| 87807 | <1% | 325 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,982 | $2K |
| 0001A | <1% | 58 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 16,337 | $2K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 55 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,411 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,988 | $2K |
| 96160 | <1% | 934 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 306 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,904 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $1K |
| 84439 | <1% | 3,031 | $1K | |
| 82728 | <1% | 1,556 | $1K | |
| 99490 | Ccm add 20min | <1% | 450 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 405 | $1K |
| 81002 | <1% | 830 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 187 | $1K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 216 | $1K |
| 87081 | <1% | 130 | $966.19 | |
| 0002A | <1% | 68 | $954.00 | |
| 87430 | <1% | 31 | $943.07 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 189 | $827.05 |
| 82607 | <1% | 1,747 | $811.76 | |
| 87481 | <1% | 167 | $655.91 | |
| 83550 | <1% | 1,479 | $635.26 | |
| 83540 | <1% | 1,545 | $548.06 | |
| 87186 | <1% | 1,210 | $522.02 | |
| 95816 | <1% | 14 | $515.64 | |
| 86803 | <1% | 701 | $466.90 | |
| 87480 | <1% | 184 | $419.36 | |
| 86780 | <1% | 39 | $407.88 | |
| 90686 | <1% | 3,948 | $404.62 | |
| 82043 | <1% | 4,103 | $360.23 | |
| 82570 | <1% | 4,047 | $323.85 | |
| 99443 | <1% | 18 | $284.48 | |
| 81001 | <1% | 3,462 | $259.80 | |
| 87070 | <1% | 86 | $234.74 | |
| 87077 | <1% | 979 | $228.87 | |
| 86140 | <1% | 903 | $218.17 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,999 | $203.88 |
| 83880 | <1% | 447 | $163.80 | |
| 85027 | <1% | 176 | $150.66 | |
| 82746 | <1% | 203 | $121.08 | |
| 86762 | <1% | 12 | $120.87 | |
| 87340 | <1% | 59 | $115.20 | |
| 90621 | <1% | 173 | $107.58 | |
| 81003 | <1% | 773 | $106.60 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $100.12 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 68 | $85.56 |
| 83655 | <1% | 13 | $81.36 | |
| 85652 | <1% | 951 | $79.94 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 16 | $51.33 |
| 82105 | <1% | 36 | $40.87 | |
| 83970 | <1% | 175 | $34.68 | |
| 83735 | <1% | 406 | $32.94 | |
| 0064U | <1% | 18 | $27.42 | |
| 82950 | <1% | 16 | $26.58 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 242 | $18.92 |
| 84550 | <1% | 451 | $18.62 | |
| 99173 | <1% | 5,356 | $17.50 | |
| 0065U | <1% | 15 | $15.83 | |
| 84436 | <1% | 196 | $10.96 | |
| 99497 | <1% | 126 | $10.36 | |
| 84479 | <1% | 180 | $10.32 | |
| 84156 | <1% | 103 | $6.84 | |
| 90651 | <1% | 425 | $0.65 | |
| 90734 | <1% | 231 | $0.49 | |
| 90619 | <1% | 147 | $0.36 | |
| 90672 | <1% | 30 | $0.02 | |
| 90698 | 0% | 112 | $0.00 | |
| 3060F | 0% | 179 | $0.00 | |
| 1111F | 0% | 1,196 | $0.00 | |
| 3061F | 0% | 380 | $0.00 | |
| 3044F | 0% | 5,325 | $0.00 | |
| 90656 | 0% | 135 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 65 | $0.00 |
| 36416 | 0% | 13 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 116 | $0.00 |
| 80069 | 0% | 105 | $0.00 | |
| 84153 | 0% | 13 | $0.00 | |
| 4010F | 0% | 31 | $0.00 | |
| 82550 | 0% | 16 | $0.00 | |
| 1123F | 0% | 26 | $0.00 | |
| 3725F | 0% | 2,277 | $0.00 | |
| 3046F | 0% | 325 | $0.00 | |
| 90670 | 0% | 110 | $0.00 | |
| 81513 | 0% | 16 | $0.00 | |
| 99051 | 0% | 16 | $0.00 | |
| 90662 | 0% | 58 | $0.00 | |
| 90682 | 0% | 47 | $0.00 | |
| 3062F | 0% | 61 | $0.00 | |
| 99358 | Prolong nursin fac eval 15m | 0% | 12 | $0.00 |
| 84481 | 0% | 27 | $0.00 | |
| 90633 | 0% | 16 | $0.00 | |
| 99498 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREEVES, JENNIFER (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Angels Harbor | Belpre, OH | $2.28M |
| Healthtexas Provider Network | Plano, TX | $1.31M |
| Healthtexas Provider Network | Colleyville, TX | $32K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.